A recent systematic review concluded that ursodeoxycholic acid (UDCA) can reduce reactive oxygen species (ROS), tumor necrosis factor-alpha (TNFα), and interleukin-1 beta (IL-1β), thereby exerting anti-apoptotic, antioxidant, and anti-inflammatory effects in AD [179]. This evidence concerns the gene IL1B and Alzheimer disease.